Why Veeva Systems (VEEV) Is Buying Veracity Logic

By Noah Long ● Dec 14, 2021
  • Veeva Systems (NYSE: VEEV) recently announced it has acquired Veracity Logic. These are the details.

Veeva Systems (NYSE: VEEV) recently announced it has acquired Veracity Logic, a provider of cloud software for randomization and trial supply management (RTSM). And the Veracity Logic team will join Veeva to deliver industry-leading software and services, helping companies simplify complex processes and expedite clinical trials.

The solution — offered as Veeva RTSM — delivers fast setup timelines and a configurable feature set to meet a broad array of randomization and supply needs. And it has supported over 175 trials with sites in 60 countries, covering a range of trial designs and complexities across all therapeutic areas in pharma/biotech, medical device, and diagnostics.

Veeva is committed to continuity and openness for Veeva RTSM customers and Veeva’s RTSM partners including, Almac Group, S-CLINICA, Signant Health, Suvoda, and 4G Clinical. And new and existing customers will have the choice to integrate Veeva RTSM with any EDC system and to use Veeva EDC with any RTSM system.

Veeva RTSM will be led by founder Steve Zimmerman as general manager, current President David Goldston as vice president of sales, and Natalie Townsend as vice president of strategy. 

KEY QUOTES:

“We are pleased to have the Veracity Logic team join Veeva and look forward to bringing RTSM excellence to our customers. This expands Veeva’s clinical offering with flexible and user-friendly RTSM capabilities.”

— Jim Reilly, vice president, Vault R&D and Quality at Veeva Systems

“We are excited to join Veeva. This acquisition is great for our customers and employees. Joining Veeva allows us to scale our solution to a wider market while continuing to deliver customer success.”

— Steve Zimmerman, Veracity Logic founder

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.